White label ELPA - ClinicalTrials.eu

Study on 68Ga-FAPI-46 and Fludeoxyglucose (18F) for Diagnosing Stomach and Gastroesophageal Junction Cancer in Patients Undergoing Chemotherapy

Not recruiting

2 1 1 1
Investigated diseases:
- Gastric cancer
- Gastrooesophageal cancer
Investigated drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
- Fludeoxyglucose (18F)
Study on the Safety and Effectiveness of ABC008 for Patients with Inclusion Body Myositis

Not recruiting

4 1
Investigated diseases:
- Inclusion body myositis
Investigated drugs:
- ULVIPRUBART
Study on Montelukast for Pain Relief in Patients with Erosive Hand Osteoarthritis

Not recruiting

2 1
Investigated diseases:
- Osteoarthritis
Investigated drugs:
- Montelukast
Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

Not recruiting

2 1
Investigated diseases:
- Asthma
Investigated drugs:
- Tanimilast
+4
Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer

Not recruiting

3 1 1
Investigated diseases:
- Breast cancer
Investigated drugs:
+7
Study on Empagliflozin for Patients with Aortic Stenosis After Aortic Valve Replacement

Not recruiting

3 1 1
Investigated diseases:
- Aortic stenosis
Investigated drugs:
- Empagliflozin
Study on Methotrexate, Tafasitamab, Lenalidomide, and Rituximab for Patients with Primary Central Nervous System Lymphoma Not Eligible for Stem Cell Transplant

Not recruiting

2 1 1 1
Investigated diseases:
- Central nervous system lymphoma
Investigated drugs:
Study on the Accuracy of OWL-EVO1 Test for Diagnosing Lung Cancer in Patients Eligible for Screening or with Suspicious CT Findings

Not recruiting

2 1 1
Investigated diseases:
Investigated drugs:
- D5-Ethyl-Beta-D-Glucuronide
Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Not recruiting

3 1 1 1
Investigated diseases:
- Asthma
Investigated drugs:
+5
Study of Pembrolizumab with Chemotherapy for High-Risk Early-Stage ER+/HER2- Breast Cancer Patients

Not recruiting

3 1 1
Investigated diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated drugs:
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies